11. Serum antibodies to human leucocyte antigen (HLA)‐E, HLA‐F and HLA‐G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA‐F autoantibodies. (16th December 2015) Authors: Jucaud, V.; Ravindranath, M. H.; Terasaki, P. I.; Morales‐Buenrostro, L. E.; Hiepe, F.; Rose, T.; Biesen, R. Journal: Clinical and experimental immunology Issue: Volume 183:Number 3(2016:Mar.) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. THU0195 IFNα and its response proteins IP-10 and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus. (23rd January 2014) Authors: Rose, T.; Gruetzkau, A.; Dähnrich, C.; Dzionek, A.; Hirseland, H.; Riemekasten, G.; Schlumberger, W.; Enghard, P.; Radbruch, A.; Burmester, G.-R.; Hiepe, F.; Biesen, R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. THU0469 Quantifying the treatment with glucocorticoids as a risk factor for the occurrence of osteoporosis and fractures in patients with ra. (12th June 2018) Authors: Wiebe, E.; Biesen, R.; Zeiner, K.N.; Freier, D.C.; Hermann, S.; Burmester, G.-R.; Buttgereit, F. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗